Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

Precision Therapeutics in Neonates: How to Improve Drug Dosing and Drug Response

For Providers
Tuesday, April 20, 2021

12 p.m. - 1 p.m.

Add to Calendar 20-04-2021 12:00:00 20-04-2021 13:00:00 15

Tamorah R. Lewis, M.D., Ph.D., presents this topic in the Enrichment Lecture Series hosted by the Center for Translational Research at Children's National Hospital.

Email us to register for this event.This Enrichment Series webinar hosted by the Center of Translational Research, will feature Tamorah R. Lewis, M.D., Ph.D., as our guest lecturer.Tamorah R. Lewis, M.D., Ph.D., is a neonatologist and translational researcher in neonatal and perinatal Pharmacology. As an assistant professor in the Department of Pediatrics at The University of Missouri, Kansas City School of Medicine, she is a physician scientist, spending 25% of her time as an attending in our Level IV NICU and 75% of her time designing, implementing and managing clinical research programs in neonatal pharmacology at Children’s Mercy Hospital. The overarching goal of her research program is to bring precision therapeutics to the NICU population using modern pharmacology tools. The research program focuses on pharmacokinetics, pharmacodynamics and pharmacogenetics of both old and new drugs used to treat neonatal disease, with an emphasis on optimizing and individualizing drug therapy in neonates.For questions about this lecture or registration information, please contact us. false DD/MM/YYYY

Email us to register for this event.

This Enrichment Series webinar hosted by the Center of Translational Research, will feature Tamorah R. Lewis, M.D., Ph.D., as our guest lecturer.

Tamorah R. Lewis, M.D., Ph.D., is a neonatologist and translational researcher in neonatal and perinatal Pharmacology. As an assistant professor in the Department of Pediatrics at The University of Missouri, Kansas City School of Medicine, she is a physician scientist, spending 25% of her time as an attending in our Level IV NICU and 75% of her time designing, implementing and managing clinical research programs in neonatal pharmacology at Children’s Mercy Hospital. The overarching goal of her research program is to bring precision therapeutics to the NICU population using modern pharmacology tools. The research program focuses on pharmacokinetics, pharmacodynamics and pharmacogenetics of both old and new drugs used to treat neonatal disease, with an emphasis on optimizing and individualizing drug therapy in neonates.

For questions about this lecture or registration information, please contact us.